[ad_1]
The Oxford-AstraZeneca vaccination campaign in South Africa was scheduled to start on Monday.
The Covid-19 epidemic has already killed more than 2.3 million people around the world. The normal life of billions of people has stagnated.
Researchers from the University of the Witwatersrand and the University of Oxford say the AstraZeneca vaccine works poorly against the South African strain of the coronavirus, which causes mild to moderate infections, especially in young people.
Andrew Pollard, chief observer for the Oxford Vaccine Trial, said: “The coronavirus will attempt to infect people who have been vaccinated. This is a normal characteristic of a virus. That fact must be taken into account:” Our research confirms that the coronavirus is treating to change their ability to survive the vaccine. “
That is why the South African government has decided to suspend the vaccination program for Astrageneca for now, the country’s health minister, Willie Mkhije, said on Sunday. “The government is waiting for the advice of scientists to find out what is the best way,” he said.
The AstraZeneca Kovid-19 vaccine was a beacon of hope for African countries. This vaccine is relatively inexpensive. Also, the AstraZeneca vaccine is easier to transport and store than the Pfizer vaccine. As a result, the poorest countries in Africa were waiting for this vaccine to fight the Kovid-19 epidemic. The new research data is definitely a big disappointment to them.
If vaccines against current and new strains of coronavirus do not work as well as expected, the world may have to continue waging a costlier war against the epidemic for longer than expected.
[ad_2]
